Molecular Characterization of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using EGFR, CDKN2A, and HRAS Alterations
Cancers · 10.12.2025 · 17 (24) · 3949
DOI: 10.3390/cancers17243949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 10.12.2025. Verfasst von Satoshi Okubo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nagoya 464-8651, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT, Japan.
Abstract (Originalsprache)
Background/Objectives: Oral squamous cell carcinoma (OSCC) often presents at an advanced stage; therefore, the early detection of precursor lesions is crucial. However, the risk assessment of precursor lesions such as oral epithelial dysplasia (OED) remains challenging because of the subjectivity of histopathological grading. We aimed to identify molecular markers that enhance the diagnostic accuracy and prognostic stratification of OSCC and explore the differences in the molecular characterization of OED and OSCC using a few selected markers. Methods: A two-step diagnostic workflow was applied: (1) FISH evaluation of EGFR amplification and CDKN2A deletion to distinguish OED from OSCC and identify EGFR-dependent tumors, and (2) HRAS immunohistochemistry performed exclusively in EGFR-negative OSCCs to stratify EGFR-independent cases. Fluorescence in situ hybridization (FISH) was used to assess seven EGFR/cell cycle-related genes (CCND1, CDKN2A, EGFR, PIK3CA, PTEN, TP53, and 1p36 locus) in 117 formalin-fixed paraffin-embedded samples (66 OED and 51 OSCC) and 10 normal mucosa samples. HRAS expression was evaluated using immunohistochemistry (IHC) in 36 EGFR amplification-negative OSCCs samples. Results:EGFR amplification was frequent in OSCC, whereas CDKN2A deletion was common in OED. The EGFR-amplified/ CDKN2A-intact profile showed high specificity for OSCC and improved diagnostic performance (area under the curve = 0.77) when combined with the Ki-67 labeling index. It also predicted poor disease-free survival (hazard ratio [HR] = 5.08, p = 0.016) and overall survival (HR = 6.10, p = 0.047). Among EGFR-negative OSCCs, HRAS overexpression was associated with advanced-stage disease and a poor prognosis (HR = 6.15, p = 0.043). Conclusions:EGFR amplification was frequent in OSCC, and CDKN2A deletion was prevalent in OED, supporting their use as molecular markers for differential diagnoses. FISH for EGFR/CDKN2A and HRAS IHC can stratify OSCC by diagnosis and prognosis, enabling practical molecular subclassification, including EGFR-negative cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nagoya 464-8651, Japan.
- Department of Internal Medicine, School of Dentistry, Aichi Gakuin University, Nagoya 464-8651, Japan.
- Department of Gastroenterology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya 466-8650, Japan.
- Department of Oral Pathology/Forensic Odontology, School of Dentistry, Aichi Gakuin University, Nagoya 464-8650, Japan.
- Division of Analytical Pathology, Oncology Innovation Center, Research Promotion Headquarters, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.
- Department of Oral & Maxillofacial Surgery, Sharad Pawar Dental College, Datta Meghe Institute of Medical Sciences, Wardha 442001, India.
ORCID-Profile: Megumi Miyabe, Katsuyuki Miyabe, Yoshihiko Sugita, Saman Warnakulasuriya, Toru Nagao
Förderung
- MEXT, Japan
Zitieren
APA
Okubo, S., Miyabe, S., Fukumura, M., Sasaki, J., Fujii, H., Terasawa, F., Watanabe, S., Okada, S., Miyabe, M., Miyabe, K., Sugita, Y., Maeda, H., Nakaya, S., Sakane, K., Yamada, S., Bhola, N., Warnakulasuriya, S., Nagao, T., & Goto, M. (2025). Molecular Characterization of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using EGFR, CDKN2A, and HRAS Alterations. Cancers, 17(24), 3949. https://doi.org/10.3390/cancers17243949
Vancouver
Okubo S, Miyabe S, Fukumura M, Sasaki J, Fujii H, Terasawa F, et al. Molecular Characterization of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using EGFR, CDKN2A, and HRAS Alterations. Cancers. 2025;17(24):3949. doi:10.3390/cancers17243949
BibTeX
@article{Okubo2025,
author = {Okubo, Satoshi and Miyabe, Satoru and Fukumura, Masahiro and Sasaki, Jun and Fujii, Hitoshi and Terasawa, Fumitaka and Watanabe, Satoshi and Okada, Soma and Miyabe, Megumi and Miyabe, Katsuyuki and Sugita, Yoshihiko and Maeda, Hatsuhiko and Nakaya, Sanako and Sakane, Kaori and Yamada, Seiji and Bhola, Nitin and Warnakulasuriya, Saman and Nagao, Toru and Goto, Mitsuo},
title = {Molecular Characterization of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using EGFR, CDKN2A, and HRAS Alterations},
journal = {Cancers},
year = {2025},
volume = {17},
number = {24},
pages = {3949},
doi = {10.3390/cancers17243949}
}
EUVIMED